Glow Targets AI Endpoint Risks In a rapidly evolving digital landscape, the emergence of AI technologies has brought about both innovative opportunities and significant challenges. Recently, Glow has stepped into the spotlight, emerging from stealth with a valuation...
Bristol Myers Squibb Acquires Nvidia AI In a significant move that underscores the growing intersection of technology and pharmaceuticals, Bristol Myers Squibb (BMS) has announced its acquisition of an Nvidia DGX SuperPOD. This advanced AI system, built on Nvidia's...
Public Health AI Trials In an exciting development for the intersection of technology and public health, a new initiative has been launched involving generative AI tools. The Coalition for Health AI, alongside major players like OpenAI, Anthropic, and Accenture, is...